Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Nebert

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymesD W Nebert
Basic Life Sciences|January 1, 1988
Genes encoding drug-metabolizing enzymes: possible role in human diseaseD W Nebert
Environmental Health Perspectives|June 1, 1981
Genetic differences in susceptibility to chemically induced myelotoxicity and leukemiaD W Nebert
Hepatology (Baltimore, Md.)|August 1, 1991
Identification of genetic differences in drug metabolism: prediction of individual risk of toxicity or cancerD W Nebert
Nature|October 25, 1990
Drug metabolism. Growth signal pathwaysD W Nebert
American Journal of Human Genetics|February 1, 1997
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?D W Nebert
Birth Defects Original Article Series|January 1, 1981
Birth defects and the potential role of genetic differences in drug metabolismD W Nebert
European Journal of Biochemistry|August 1, 1980
Subcellular localization of membrane-bound aryl-hydrocarbon hydroxylase and NAD(P)H-dependent reductase activities in mouse liverI Kano, D W Nebert
The Journal of Biological Chemistry|March 25, 1981
Structural gene products of the Ah complex. Increases in large mRNA from mouse liver associated with cytochrome P1-450 induction by 3-methylcholanthreneM Negishi, D W Nebert
Pharmacological Reviews|June 1, 1982
Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesisO Pelkonen, D W Nebert
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymesD W Nebert
Basic Life Sciences|January 1, 1988
Genes encoding drug-metabolizing enzymes: possible role in human diseaseD W Nebert
Environmental Health Perspectives|June 1, 1981
Genetic differences in susceptibility to chemically induced myelotoxicity and leukemiaD W Nebert
Hepatology (Baltimore, Md.)|August 1, 1991
Identification of genetic differences in drug metabolism: prediction of individual risk of toxicity or cancerD W Nebert
Nature|October 25, 1990
Drug metabolism. Growth signal pathwaysD W Nebert
American Journal of Human Genetics|February 1, 1997
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?D W Nebert
Birth Defects Original Article Series|January 1, 1981
Birth defects and the potential role of genetic differences in drug metabolismD W Nebert
European Journal of Biochemistry|August 1, 1980
Subcellular localization of membrane-bound aryl-hydrocarbon hydroxylase and NAD(P)H-dependent reductase activities in mouse liverI Kano, D W Nebert
The Journal of Biological Chemistry|March 25, 1981
Structural gene products of the Ah complex. Increases in large mRNA from mouse liver associated with cytochrome P1-450 induction by 3-methylcholanthreneM Negishi, D W Nebert
Pharmacological Reviews|June 1, 1982
Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesisO Pelkonen, D W Nebert
Pageof 35